Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 2:09 pm Purchase |
2025-06-09 | 13G | Aytu BioPharma, Inc. AYTU |
LYTTON LAURENCE W | 506,605 5.600% |
506,605 (New Position) |
Filing History |
| 2025-05-16 5:41 pm Purchase |
2025-05-12 | 13G | Sonim Technologies, Inc. SONM |
LYTTON LAURENCE W | 2,066,916 19.300% |
1,200,000 (+138.42%) |
Filing History |
| 2025-05-15 3:51 pm Sale |
2025-03-31 | 13G | Evoke Pharma, Inc. EVOK |
LYTTON LAURENCE W | 61,274 3.900% |
-13,483 (-18.04%) |
Filing History |
| 2025-05-15 3:50 pm Sale |
2025-03-31 | 13G | SmartKem, Inc. SMTK |
LYTTON LAURENCE W | 222,721 4.900% |
-110,612 (-33.18%) |
Filing History |
| 2025-05-15 3:49 pm Sale |
2025-03-31 | 13G | NeuroOne Medical Technologies Corporation NMTC |
LYTTON LAURENCE W | 1,295,288 2.600% |
-764,634 (-37.12%) |
Filing History |
| 2025-05-15 3:29 pm Sale |
2025-03-31 | 13G | Creative Realities, Inc. CREX |
LYTTON LAURENCE W | 524,363 5.000% |
-137,028 (-20.72%) |
Filing History |
| 2025-05-15 3:27 pm Sale |
2025-03-31 | 13G | Biofrontera Inc. BFRI |
LYTTON LAURENCE W | 306,700 3.500% |
-248,184 (-44.73%) |
Filing History |
| 2025-04-16 2:11 pm Purchase |
2025-04-15 | 13G | Xtant Medical Holdings, Inc. XTNT |
LYTTON LAURENCE W | 9,463,442 6.800% |
9,463,442 (New Position) |
Filing History |
| 2025-02-24 11:48 am Purchase |
2025-02-20 | 13G | Sonim Technologies, Inc. SONM |
LYTTON LAURENCE W | 866,916 17.800% |
401,400 (+86.23%) |
Filing History |
| 2025-02-13 3:55 pm Sale |
2024-12-31 | 13G | Creative Realities, Inc. CREX |
LYTTON LAURENCE W | 661,391 6.300% |
-122,609 (-15.64%) |
Filing History |
| 2025-02-13 3:49 pm Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 3,955,470 8.800% |
-434,499 (-9.90%) |
Filing History |
| 2025-02-13 3:45 pm Purchase |
2024-01-31 | 13G | Duos Technologies Group, Inc. DUOT |
LYTTON LAURENCE W | 427,002 4.990% |
26,434 (+6.60%) |
Filing History |
| 2025-02-13 3:31 pm Purchase |
2024-12-31 | 13G | MDxHealth SA MDXH |
LYTTON LAURENCE W | 3,949,385 8.400% |
1,058,790 (+36.63%) |
Filing History |
| 2025-02-13 3:26 pm Sale |
2024-12-31 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 126,948 1.400% |
-359,537 (-73.91%) |
Filing History |
| 2025-02-05 4:16 pm Purchase |
2025-01-30 | 13G | Sonim Technologies, Inc. SONM |
LYTTON LAURENCE W | 465,516 9.600% |
465,516 (New Position) |
Filing History |
| 2024-12-23 6:52 pm Purchase |
2024-12-20 | 13G | SmartKem, Inc. SMTK |
LYTTON LAURENCE W | 333,333 9.400% |
333,333 (New Position) |
Filing History |
| 2024-12-23 6:51 pm Purchase |
2024-12-17 | 13G | Electrovaya Inc. ELVA |
LYTTON LAURENCE W | 2,443,309 6.200% |
2,443,309 (New Position) |
Filing History |
| 2024-11-26 08:42 am Purchase |
2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC |
LYTTON LAURENCE W | 2,059,922 6.600% |
755,820 (+57.96%) |
Filing History |
| 2024-11-14 3:58 pm Purchase |
2024-09-30 | 13G | scPharmaceuticals Inc. SCPH |
LYTTON LAURENCE W | 2,944,932 5.900% |
1,119,698 (+61.35%) |
Filing History |
| 2024-11-14 1:26 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 4,389,969 9.990% |
1,109,791 (+33.83%) |
Filing History |